Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (38)
Noémie Jourde-Chiche, Laurent Daniel, Laurent Chiche, Daniel Bertin, Chantal Dumestre-Pérard, Stéphane Burtey & Nathalie Bardin. (2022) Rôle du complément dans la néphropathie lupique et la néphropathie du syndrome des anti-phospholipides. La Presse Médicale Formation 3:2, pages 156-163.
Crossref
Crossref
Tingting Liu, Jing Han, Rongrong Zhang, Zihan Tang, Gang Yi, Wen Gong, Liyan Wan, Qiongyi Hu, Jialin Teng, Honglei Liu, Xiaobing Cheng, Junna Ye, Yutong Su, Yue Sun, Yi Shi, Jianxin Gu, Shifang Ren, Chengde Yang & Hui Shi. (2022) Characteristics of purified anti-β2GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome. Rheumatology 61:3, pages 1243-1254.
Crossref
Crossref
Luis Ramos Ruperto, Carmen Busca Arenzana, Angel Robles Marhuenda & Jose I. Bernardino. 2022. Translational Autoimmunity. Translational Autoimmunity
141
167
.
Arzu Soybilgic & Tadej Avcin. (2020) Pediatric APS: State of the Art. Current Rheumatology Reports 22:3.
Crossref
Crossref
Thomas McDonnell, Chris Wincup, Ina Buchholz, Charis Pericleous, Ian Giles, Vera Ripoll, Hannah Cohen, Mihaela Delcea & Anisur Rahman. (2020) The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS. Blood Reviews 39, pages 100610.
Crossref
Crossref
Thomas McDonnell, Bahar Artim-Esen, Chris Wincup, Vera M. Ripoll, David Isenberg, Ian P. Giles, Anisur Rahman & Charis Pericleous. (2018) Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I. Frontiers in Immunology 9.
Crossref
Crossref
N Abdel-Wahab, S Talathi, M A Lopez-Olivo & M E Suarez-Almazor. (2017) Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis. Lupus 27:4, pages 572-583.
Crossref
Crossref
Mirjana Bećarević. (2017) Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome—Biomarkers of the Disease and Biopharmaceuticals. Current Rheumatology Reports 19:7.
Crossref
Crossref
Joyce Rauch, Miri Blank, Philip G. de Groot, Kathryn M. Dupnik, Martin Alexander Kriegel, Jerrold S. Levine, Yehuda Shoenfeld & Rohan Willis. 2017. Antiphospholipid Syndrome. Antiphospholipid Syndrome
29
52
.
Jasmin KnopfMona HC BiermannLuis E MuñozMartin Herrmann. (2021) Antibody glycosylation as a potential biomarker for chronic inflammatory autoimmune diseases. AIMS Genetics 03:04, pages 280-291.
Crossref
Crossref
Kenji Oku, Hiroyuki Nakamura, Michihiro Kono, Kazumasa Ohmura, Masaru Kato, Toshiyuki Bohgaki, Tetsuya Horita, Shinsuke Yasuda, Olga Amengual & Tatsuya Atsumi. (2016) Complement and thrombosis in the antiphospholipid syndrome. Autoimmunity Reviews 15:10, pages 1001-1004.
Crossref
Crossref
Kenji Oku, Olga Amengual, Ryo Hisada, Kazumasa Ohmura, Ikuma Nakagawa, Toshiyuki Watanabe, Toshiyuki Bohgaki, Tetsuya Horita, Shinsuke Yasuda & Tatsuya Atsumi. (2016) Autoantibodies against a complement component 1 q subcomponent contribute to complement activation and recurrent thrombosis/pregnancy morbidity in anti-phospholipid syndrome. Rheumatology 55:8, pages 1403-1411.
Crossref
Crossref
Trisha A. Rettig, Julie N. Harbin, Adelaide Harrington, Leonie Dohmen & Sherry D. Fleming. (2015) Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer. Clinical Immunology 160:2, pages 244-254.
Crossref
Crossref
Cassyanne L. Aguiar, Arzu Soybilgic, Tadej Avcin & Barry L. Myones. (2015) Pediatric Antiphospholipid Syndrome. Current Rheumatology Reports 17:4.
Crossref
Crossref
Christoph Fickentscher, Iryna Magorivska, Christina Janko, Mona Biermann, Rostyslav Bilyy, Cecilia Nalli, Angela Tincani, Veronica Medeghini, Antonella Meini, Falk Nimmerjahn, Georg Schett, Luis E. Muñoz, Laura Andreoli & Martin Herrmann. (2015)
The Pathogenicity of Anti-
β
2GP1-IgG Autoantibodies Depends on Fc Glycosylation
. Journal of Immunology Research 2015, pages 1-12.
Crossref
Crossref
Yuan-Yuan Wu, Andrew V. Nguyen, Xiao-Xuan Wu, Mingyu Loh, Michelle Vu, Yiyu Zou, Qiang Liu, Peng Guo, Yanhua Wang, Leslie L. Montgomery, Amos Orlofsky, Jacob H. Rand & Elaine Y. Lin. (2014) Antiphospholipid Antibodies Promote Tissue Factor–Dependent Angiogenic Switch and Tumor Progression. The American Journal of Pathology 184:12, pages 3359-3375.
Crossref
Crossref
Maria Laura Bertolaccini, Olga Amengual, Laura Andreoli, Tatsuya Atsumi, Cecilia B. Chighizola, Ricardo Forastiero, Philip de Groot, Gabriella Lakos, Marc Lambert, Pierluigi Meroni, Thomas L. Ortel, Michelle Petri, Anisur Rahman, Robert Roubey, Savino Sciascia, Melissa Snyder, Anne E. Tebo, Angela Tincani & Rohan Willis. (2014) 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmunity Reviews 13:9, pages 917-930.
Crossref
Crossref
Anna Brusch, Christine Bundell & Peter Hollingsworth. (2014) Immunoglobulin G is the only anti-beta-2-glycoprotein I isotype that associates with unprovoked thrombotic events among hospital patients. Pathology 46:3, pages 234-239.
Crossref
Crossref
Laura Andreoli, Micaela Fredi, Cecilia Nalli, Silvia Piantoni, Rossella Reggia, Francesca Dall’Ara, Franco Franceschini & Angela Tincani. (2013) Clinical Significance of IgA Anti-Cardiolipin and IgA Anti-β2Glycoprotein I Antibodies. Current Rheumatology Reports 15:7.
Crossref
Crossref
Caroline Grönwall, Ehtisham Akhter, Cheongeun Oh, Rufus W. Burlingame, Michelle Petri & Gregg J. Silverman. (2012) IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE. Clinical Immunology 142:3, pages 390-398.
Crossref
Crossref
Keith B. Elkon & Gregg J. Silverman. 2012. Naturally Occurring Antibodies (NAbs). Naturally Occurring Antibodies (NAbs)
14
26
.
Alexey Kolyada, Chang-Jin Lee, Alfredo De Biasio & Natalia Beglova. (2010) A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid Syndrome. PLoS ONE 5:12, pages e15345.
Crossref
Crossref
Ivan K. H. Poon, Mark D. Hulett & Christopher R. Parish. (2010) Histidine-rich glycoprotein is a novel plasma pattern recognition molecule that recruits IgG to facilitate necrotic cell clearance via FcγRI on phagocytes. Blood 115:12, pages 2473-2482.
Crossref
Crossref
Bill Giannakopoulos, Freda Passam, Yiannis Ioannou & Steven A. Krilis. (2009) How we diagnose the antiphospholipid syndrome. Blood 113:5, pages 985-994.
Crossref
Crossref
U. A. Walker, A. Tyndall & T. Daikeler. (2008) Rheumatic conditions in human immunodeficiency virus infection. Rheumatology 47:7, pages 952-959.
Crossref
Crossref
Navin M. Amin. (2008) Antiphospholipid Syndromes in Infectious Diseases. Hematology/Oncology Clinics of North America 22:1, pages 131-143.
Crossref
Crossref
Yaniv Sherer, Miri Blank & Yehuda Shoenfeld. (2007) Antiphospholipid syndrome (APS): Where does it come from?. Best Practice & Research Clinical Rheumatology 21:6, pages 1071-1078.
Crossref
Crossref
Barbara Salobir, Mišo Šabovič, Maja Hojnik, Saša Čučnik & Tanja Kveder. (2007) Anti-β2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease. Immunobiology 212:3, pages 193-199.
Crossref
Crossref
Y Levy, O Almog, A Gorshtein & Y Shoenfeld. (2016) The environment and antiphospholipid syndrome. Lupus 15:11, pages 784-790.
Crossref
Crossref
M. Samarkos, K. A. Davies, C. Gordon & S. Loizou. (2006) Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Clinical Rheumatology 25:2, pages 199-204.
Crossref
Crossref
Ricard Cervera & Ronald A. Asherson. (2005) Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics. Immunobiology 210:10, pages 735-741.
Crossref
Crossref
Nuno Germano, Paula Mendonça & António Murinello. (2005) Tromboembolismo pulmonar associado a infecção VIH. Revista Portuguesa de Pneumologia 11:4, pages 407-412.
Crossref
Crossref
Nadia Schiavo, Andrei Lemos Lottermann, Fernanda Pires Costa & Henrique Luiz Staub. (2005) ANTIPHOSPHOLIPID ANTIBODIES, THROMBOSIS, AND ADENOCARCINOMA. Clinics 60:3, pages 257-258.
Crossref
Crossref
Wei H Chen, Yi F Kao & Jia S Liu. (2005) An increase of blood anti-beta2-glycoprotein I antibody in Japanese encephalitis associated with cerebral ischemia. Blood Coagulation & Fibrinolysis 16:1, pages 55-59.
Crossref
Crossref
Gisele Zandman-Goddard & Yehuda Shoenfeld. 2004. Infection and Autoimmunity. Infection and Autoimmunity
171
179
.
Gisele Zandman-Goddard & Yehuda Shoenfeld. (2002) HIV and autoimmunity. Autoimmunity Reviews 1:6, pages 329-337.
Crossref
Crossref
Gisele Zandman-Goddard, Miri Blank & Yehuda Shoenfeld. 2002. The Antiphospholipid Syndrome II. The Antiphospholipid Syndrome II
343
358
.
A N Leder, B Flansbaum, G Zandman-Goddard, R Asherson & Y Shoenfeld. (2016) Antiphospholipid syndrome induced by HIV. Lupus 10:5, pages 370-374.
Crossref
Crossref